Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ITI-007 versus placebo administered orally once daily in the treatment of agitation in patients with dementia, including Alzheimer's disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02817906
Study type Interventional
Source Intra-Cellular Therapies, Inc.
Contact
Status Terminated
Phase Phase 3
Start date August 29, 2016
Completion date January 30, 2019

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06216275 - Enhancing Calm in Arab Elderly With Dementia N/A
Not yet recruiting NCT06451952 - Virtual Darkness Theraphy for Agitation in Dementia N/A